The IPO has witnessed a significant jump in its Grey Market Premium (GMP), which currently stands at Rs 25 per share, indicating a positive market sentiment towards the issue.
The category for non-institutional investors received 2.97 times subscription, while the portion for Qualified Institutional Buyers (QIBs) was subscribed 1.74 times and Retail Individual Investors' (RIIs) 96 per cent.
The total size of the public issue is 22. 80 lakh shares. The IPO aims to raise Rs 54. 04 crore. The issue comprises of fresh issue of 14. 80 lakh equity shares amounting to Rs 35. 08 crore and an offer for sale (OFS) of up to 8 lakh shares worth Rs 18.96 crore.
The frozen meat exporter company's share sale offer comprises a fresh issue of more than 25 lakh fresh shares. It has an Offer for Sale (OFS) component of over 56 lakh shares.
According to Nikhil Bhatt, a SEBI registered analyst, considering the positive financial performance and growth potential, coupled with its strong presence in the retail industry, Cell Point India could be a good buy for long-term gains.
The Agra-based firm is among the largest exporters of frozen buffalo meat products from India. Its products are exported to over 40 countries all over the globe. More than 90 per cent of its sales comes from exports.
The shares were listed on the NSE SME platform and are currently trading at a premium of more than 40 per cent from the IPO issue price of Rs 76.
The stock closed at Rs 155.61 apiece on the listing day. The company commanded a market cap of Rs 159.09 crore as on the listing day.
The allotment will be finalised on April 12 by the company. Unistone Capital Pvt Ltd is the Book Running Lead Manager (BRLM) to the issue and Skyline Financial Services Pvt Ltd. is the registrar.
A retail investor can bid for a maximum of 1 lot comprising 1200 shares. One lot will cost Rs 118,800. HNI investors can bid for two lots (2400 shares for Rs 237,600).
According to the terms of the offer, qualified institutional buyers (QIBs) are entitled to 50 per cent of the net offer, HNIs and NIIs to 15 per cent and retail investors to the remaining 35 per cent.
The public issue comprises 2,328,000 equity shares. The company aims to raise Rs 23.74 crore, according to a circular uploaded on BSE's website.
Established in 1982, Patron Exim operates primarily in the pharmaceutical, chemical industries and adjacent industries. The company manufactures and distributes surgical and non-surgical products, active pharmaceutical ingredients, drug intermediates and other products.
The price range for the offer has been set at Rs 96 to Rs 102 per share. The company's IPO comprises 2,328,000 equity shares with a face value of Rs 10.
The SME IPO aims to garner Rs 35 crore through its initial share sale. The company has set a price band of Rs 55 to Rs 57.
Here is a list of some of the upcoming IPOS (Initial Public Offering) in January 2023. The list sums up companies like Zaggle Prepaid Ocean Services Limited, Puranik Builders Limited and Indegene Limited.
According to a filing by the company, it has recorded the highest sales volumes of 91,232 thousand tonnes in the third quarter of the current fiscal, registering a 40 per cent rise on a Y-o-Y basis.
Venus Pipes made its stock market debut in May 2022. At that time, its shares made a muted start but later zoomed more than 100 per cent to double the money of investors.
Year ender 2022: The overall collection would have been much lower had it not been for the Rs 20,557-crore LIC public offer, which constitutes as much as 35 per cent of the total amount raised during the year.
Paytm has a liquidity of Rs 9,182 crore, as per its last earnings report. The company's board is scheduled to meet on December 13 to consider a share buyback proposal.
Top News
Latest News
